Spinal Plasticity to Enhance Motor Retraining After Stroke
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03645122 |
|
Recruitment Status :
Recruiting
First Posted : August 24, 2018
Last Update Posted : November 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Stroke Cerebrovascular Accident Hemiparesis | Procedure: Noninvasive neuromodulation via paired corticospinal-motoneuronal stimulation (PCMS) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 48 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Transcranial magnetic stimulation targeting the region of the brain responsible for voluntary movement control and electrical stimulation to a peripheral nerve innervating hand muscles will be triggered at an interval that elicits action potentials arriving in a set sequence and predetermined delay in the spinal cord. |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Plasticity in the Spinal Cord to Enhance Motor Retraining After Stroke |
| Actual Study Start Date : | February 4, 2019 |
| Estimated Primary Completion Date : | October 31, 2022 |
| Estimated Study Completion Date : | October 31, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Physiology
Different neural elements will be stimulated and evoked potentials will be recorded via electromyography. Metrics used to quantify evoked potentials will be used to infer changes in physiological functioning of the nervous system.
|
Procedure: Noninvasive neuromodulation via paired corticospinal-motoneuronal stimulation (PCMS)
This study is a novel approach to studying neuroplasticity after stroke. Previous work in humans with incomplete spinal cord injury demonstrates that the resulting plasticity transiently enhances motor output, indicating that there is also therapeutic potential. This study will attempt to induce bi-directional plasticity in corticospinal-motoneuronal synapses serving an intrinsic hand muscle of the hemiparetic limb. Control experiments will be completed to provide evidence of the neurophysiological mechanism(s) mediating the effect and to examine behavioral effects. |
|
Experimental: Behavior
A visuomotor task will be performed and force signals will be recorded. Metrics used to quantify force signals will be used to infer changes in control processes governing movement.
|
Procedure: Noninvasive neuromodulation via paired corticospinal-motoneuronal stimulation (PCMS)
This study is a novel approach to studying neuroplasticity after stroke. Previous work in humans with incomplete spinal cord injury demonstrates that the resulting plasticity transiently enhances motor output, indicating that there is also therapeutic potential. This study will attempt to induce bi-directional plasticity in corticospinal-motoneuronal synapses serving an intrinsic hand muscle of the hemiparetic limb. Control experiments will be completed to provide evidence of the neurophysiological mechanism(s) mediating the effect and to examine behavioral effects. |
- Physiology [ Time Frame: 12 months ]Different neural elements will be stimulated and evoked potentials will be recorded via electromyography. Metrics used to quantify evoked potentials will be used to infer changes in physiological functioning of the nervous system.
- Behavior [ Time Frame: 12 months ]A visuomotor task will be performed and force signals will be recorded. Metrics used to quantify force signals will be used to infer changes in control processes governing movement.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Between the ages of 18 and 75 years old
- Diagnosis of first-ever stroke
- Stroke onset of at least six months prior to the time of participation
Exclusion Criteria:
- History of seizure or epilepsy
- Ferromagnetic metallic implants, pacemakers, other implanted devices, or ventilators (for subjects undergoing MRI)
- Pregnant or expecting to become pregnant
- Difficulty maintaining alertness and/or remaining still
- Body weight > 300 lbs due to MRI scanner dimensions (for subjects undergoing MRI)
- Cognitive or language impairments that would interfere with the ability to follow simple instructions, as judged by the investigators
- Diagnosis of movement disorder(s) other than stroke
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03645122
| Contact: Nicholas J Gatto, BS | (412) 822-3664 | nicholas.gatto@va.gov | |
| Contact: Michael A Urbin, PhD | (412) 688-6000 | Michael.Urbin@va.gov |
| United States, Pennsylvania | |
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Recruiting |
| Pittsburgh, Pennsylvania, United States, 15240 | |
| Contact: Nicholas J Gatto, BS 412-822-3664 nicholas.gatto@va.gov | |
| Principal Investigator: Michael A. Urbin, PhD | |
| Principal Investigator: | Michael A. Urbin, PhD | VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA |
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT03645122 |
| Obsolete Identifiers: | NCT03638570, NCT03639116 |
| Other Study ID Numbers: |
B2837-W 1617296 ( Other Grant/Funding Number: Veterans Health Administration ) |
| First Posted: | August 24, 2018 Key Record Dates |
| Last Update Posted: | November 22, 2021 |
| Last Verified: | November 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
Neuromodulation Transcranial magnetic stimulation (TMS) Electrical stimulation |
|
Stroke Paresis Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases Neurologic Manifestations |

